Researchers Develop Treatment to Reverse Alopecia Areata Hair loss

Alopecia areata is one of the more severe forms of hair loss. According to leading charity Alopecia UK, around 400,000 people in the UK have experience with the condition.

Currently there is no cure, but that could be about to change thanks to researchers across the pond.

Together, researchers from the Harvard Medical School, MIT, and Brigham Women’s Hospital, have developed a promising new treatment. Here we’ll explore the findings of the recent study, and whether they could lead to a cure for alopecia areata.

New treatment triggers regrowth and reduces inflammation

Researchers from Harvard Medical School, MIT, and Brigham Women’s Hospital have made a significant step toward a potential cure for alopecia areata. The team has created an innovative microneedle patch designed to be applied painlessly to the scalp. Once in place, the patch delivers drugs that specifically target and rebalance the immune response in the affected area.

The effectiveness of this new treatment was first observed in a study conducted on mice. When the patch was applied every other day for three weeks, the results were remarkable. Not only did the treatment reduce inflammation at the site, but it also promoted significant hair regrowth.

This regrowth persisted for several weeks after the treatment had ended, a promising sign of the treatment’s long-term effectiveness.

The study also showed that the immune system’s rebalancing was localised to the site of the patch, meaning that the systemic immune functions elsewhere in the body remained unaffected. This targeted approach reduces the risk of side effects commonly associated with broader immune suppression treatments.

To further test their findings, the researchers conducted experiments using mice with a humanised immune system and grafted human skin. The results mirrored those in the initial study, showing the same reduction in inflammation and increase in hair regrowth.

The microneedle patches also demonstrated the potential to monitor treatment progress.

The patches, made from hyaluronic acid, swell once inside the skin, allowing them to absorb fluids and immune cells. This provides researchers with valuable data about the treatment’s effectiveness.

Could a microneedle patch be the cure to Alopecia Areata?

The new microneedle patch isn’t just innovative, but also highly practical. Made from hyaluronic acid crosslinked with polyethylene glycol (PEG), both biocompatible materials, the patch is designed to penetrate the tough outer layer of the skin, something that traditional creams struggle to do. This allows the drug to reach deeper into the skin where it can effectively rebalance the immune response and stimulate hair regrowth.

What current Alopecia Areata treatments are available?

While the microneedle patch offers a hopeful outlook for those suffering from alopecia areata, it’s important to recognise that more research and clinical trials are needed before it can be widely adopted. In the meantime, those affected by the condition have several treatment options to help manage symptoms.

Current treatments for alopecia areata include corticosteroids, which are anti-inflammatory drugs that can be injected into the scalp, or applied topically, to reduce inflammation and promote hair regrowth. Other options include topical immunotherapy, where chemicals are applied to the scalp to provoke an allergic reaction that encourages hair growth. There are also oral immunosuppressants, which are used in more severe cases to dampen the immune system’s attack on hair follicles.

Recently, Ritlecitinib has been recommended by NICE as an option for treating severe alopecia areata, which works by reducing the enzymes that cause inflammation and subsequent hair loss at the follicle.

If you are living with alopecia areata and want to explore your treatment options, arrange an appointment with a dermatologist that specialises in hair loss.